Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

The protocol describes a rapid, high-throughput, reliable, inexpensive, and unbiased assay for efficiently determining cellular viability. This assay is particularly useful when cells' mitochondria have been damaged, which interferes with other assays. The assay uses automated counting of cells stained with two nuclear dyes – Hoechst 33342 and propidium iodide.

Abstract

The contribution of mitochondria to oncogenic transformation is a subject of wide interest and active study. As the field of cancer metabolism becomes more complex, the goal of targeting mitochondria using various compounds that inflict mitochondrial damage (so-called mitocans) is becoming quite popular. Unfortunately, many existing cytotoxicity assays, such as those based on tetrazolium salts or resazurin require functional mitochondrial enzymes for their performance. The damage inflicted by compounds that target mitochondria often compromises the accuracy of these assays. Here, we describe a modified protocol based on differential staining with two fluorescent dyes, one of which is cell-permeant (Hoechst 33342) and the other of which is not (propidium iodide). The difference in staining allows living and dead cells to be discriminated. The assay is amenable to automated microscopy and image analysis, which increases throughput and reduces bias. This also allows the assay to be used in high-throughput fashion using 96-well plates, making it a viable option for drug discovery efforts, particularly when the drugs in question have some level of mitotoxicity. Importantly, results obtained by Hoechst/PI staining assay show increased consistency, both with trypan blue exclusion results and between biological replicates when the assay is compared to other methods.

Introduction

The first step to identifying effective cancer treatments is the selection of a robust, unbiased cytotoxicity assay that can be used to examine the effect of treatment. A common choice for low-throughput experiments is the exclusion of trypan blue dye from living cells. This method is favored because it allows a relatively unbiased method for quantifying cell survival. trypan blue passively diffuses into cells whose membranes are compromised, but it is effectively blocked from entering healthy cells1. The quotient of the living cells and the total cells represents the percent viability, which indicates the efficacy of the treatment. The most si....

Protocol

1. Cytotoxicity Assay: Setup

  1. Prepare solutions of compounds of interest at desired concentrations in the appropriate media (serum-free or 1, 2.5, or 5% FBS RPMI-1640).
    1. To measure cytotoxicity of a single compound (e.g., to determine effective doses), prepare compounds at 2x final concentration.
    2. To measure cytotoxicity of compound combinations, prepare compounds at 4x final concentration.
    3. Prepare solvent-only controls by mixing the same amount of solvent with the appropriate m.......

Representative Results

The aforementioned protocol has been developed using OCI-AML2 cells, which were taken as a representative acute myeloid leukemia cell line. AML is characterized by abnormal proliferation of undifferentiated and non-functional hematopoietic cells in the bone marrow26. Despite recent developments in AML targeted therapy, the standard of care has remained unchanged for several decades, and consists of induction therapy (typically comprised of three days of anthracycline, e.g., daunorubicin, idar.......

Discussion

Although the protocol for Hoechst/PI cytotoxicity assay is robust and requires comparatively little hands-on time, there are several experimental details that are very important to ensure accurate results. First, it is essential to make sure that the concentration of DMSO remains below 0.5% (v/v). It is generally agreed that exposure to even low doses of DMSO can substantially alter the morphology and attachment of cells and significantly delay cell cycle progression39,

Acknowledgements

NVK, a CPRIT scholar in Cancer Research, thanks the Cancer Prevention and Research Institute of Texas (CPRIT) for their generous support, CPRIT grant RR150044. This work was also supported by the Welch Foundation Research Grant C-1930, and by the National Institutes of Health R35 GM129294 awarded to NVK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

....

Materials

NameCompanyCatalog NumberComments
2-Deoxy-D-glucose/2-DGChem-Impex50-519-067
3-bromo-pyruvateAlfa Aesar1113-59-3
96-Well platesGreiner Bio-One655090Black or clear flat-bottomed 96-well plates
Alamar blue HS cell viability reagent (100mL) Thermo FisherA50101
Countess II automated cell counterThermo Fisher
Cytation 5 Cell Imaging Multi-Mode ReaderBioTek
Hoechst 33342Thermo Fisher6224920 mM solution; final concentration 1:1,000
HyClone fetal bovine serumGE Healthcare#25-514
m-chlorophenylhydrazone/CCCPSigma AldrichC2759
PBS tabletsThermo FisherBP29441001 tablet + 200 mL of sterile water = 1x PBS solution
Penicillin-Streptomycin-Glutamine (100X)Gibco10378016
Pierce LDH assay kitThermo Fisher50-103-5952
Propidium IodideThermo Fisher50-596-072Dry powder; stock 1 mg/mL in PBS; final concentration 5 µg/mL (leukemia cells), 1 µg/mL (normal PBMCs)
RotenoneArk PharmAK115691
RPMI-1640 Medium
With L-glutamine and sodium bicarbonate, liquid, sterile-filtered, suitable for cell culture
Sigma AldrichR8758-500ML
Thiazolyl blue tetrazolium bromideACROS OrganicsAC158990010
Trypan blue stain (0.4%)Gibco15250-061
Cell lines
K562ATCCCCL-243CML cell line
MOLM-13ATCCAML cell line
MOLT-4ATCCCRL-1582ALL cell line
OCI-AML2ATCCAML cell line

References

  1. Ramirez, C. N., Antczak, C., Djaballah, H. Cell viability assessment: toward content-rich platforms. Expert Opinion on Drug Discovery. 5 (3), 223-233 (2010).
  2. Melzer, S., et al. Trypan blue as an affordab....

Explore More Articles

Automated Differential Nuclear StainingMitocan CytotoxicityCell ViabilityHigh Throughput Drug ScreeningCytotoxicity DeterminationMitochondrial FunctionCell DensityTrypan Blue StainingCell SuspensionMulti channel Pipette96 well PlateDMSO Concentration

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved